Abstract Submission Guidelines
Thank you for your interest in JADPRO Live 2018. Abstract submissions are now closed.
Thank you for your interest in abstract submissions for the sixth annual JADPRO Live CE-accredited conference. The event audience will include nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists and physicians. The conference chair invites our oncology advanced practitioner attendees who are members of the Advanced Practitioner Society for Hematology and Oncology (APSHO) to submit abstracts to be considered for moderated poster presentations at the conference.
The abstract submission deadline is 11:59pm PDT on August 1, 2018.
Abstracts may be submitted by oncology advanced practitioners who are members of APSHO and plan to attend the live conference. Abstract submitters must complete all submission requirements by
11:59pm PDT on August 1, 2018 for the abstract to enter the review process and be considered for poster presentations.
The abstract deadline will not be extended. There will be no additional deadlines for late-breaking data.
Information Required for Abstract Submission
An abstract submission must include the following information by the deadline to enter the review process:
- Full name, credentials, title/position, institution, email, phone number and APSHO membership number of the submitting author
- Full name, credentials, title/position, institution, email and phone number of each co-author
- Title and complete body of abstract with appropriate sub-headings
- Pertinent references and permissions
- Completed Copyright Transfer Agreement for Abstracts (lead or representative author must complete)
- Completed Disclosure Forms (all authors listed on the abstract must complete)
- Curriculum vitae (CV) or resume of submitting author
- Declaration of submitting author's role in work and content presented in the abstract
- Confirmation of original authorship by submitting advanced practitioner
Submitters are encouraged to ask questions during the process by contacting the abstract coordinator, Kelley Moore,
kmoore@hbside.com. Likewise, if there are questions regarding the information submitted for an abstract, the submitting author will be notified. Providing references during the submission process is not required; however, submitters will have an opportunity to upload references regarded essential for review, as well as necessary permissions. Early completion of submissions is encouraged. Once the deadline has passed, changes to the abstract submission are not permitted.
Abstract Topics and Categories
The APSHO member should submit an abstract that describes a
completed initiative, the significance of the results/outcomes or conclusions, and includes implications for advanced practitioners in oncology. See more information below regarding complete and incomplete initiatives. Topics can include research, clinical/evidence-based practice, educational initiatives, leadership, professional development and advanced practice projects. Abstracts should be no more than 500 words and organized with paragraph headings. The word count does not include the title, but does include paragraph headings.
Example paragraph headings:
- Background (other options: Context, Setting, Objective, Aim, Goal, Purpose)
- Methods (other options: Design, Intervention, Approaches, Procedures, Processes)
- Results (other options: Findings, Outcome Measures, Effects, Discoveries)
- Conclusions (other options: Interpretation, Summary, Evaluation)
- Recommendations (other options: Implications, Proposals, Applications)
Abstract submitters will be required to designate a category for the abstract submission:
- Original Research
- Professional Development
- Quality of Care
It is advised that authors address within the abstract the significance and purpose for oncology advanced practice with a clear description of the role of, and implications for, the advanced practitioner.
- Tables are not allowed within abstracts but may be used on posters.
- References to drug in abstracts must be by generic name only.
- Abstract content must be objective and free from bias.
- Content must be original, novel, significant for advanced practitioners, not previously presented or published, and not submitted for consideration elsewhere.
- Encore abstracts and abstracts discussing trials in progress will not be considered for review.
Abstracts should describe completed work; however, projects in progress may be considered for review if the content provided is compelling and pertinent to the advanced practitioner prior to completion; please contact the abstract coordinator to discuss. A maximum of 10 authors will be allowed for each abstract. Abstract submitters may be contacted for clarity regarding co-author information, role or contributions. Once the deadline has passed, changes to the abstract submission are not permitted. Late-breaking data past the submission deadline may be included in the poster should the abstract be accepted. Requirements must be met and approved for an abstract to move into the review process.
Abstracts may not be written or submitted by parties on behalf of authors. Submissions of this type will be declined.
APSHO Membership Information
Members who plan to submit abstracts must be current on membership dues, have completed member profiles, and be members in good standing. For more information regarding your current membership status or to join APSHO, please visit
www.apsho.org.
Review Process
All completed abstract submissions that meet requirements will undergo review, including review by two or more peer reviewers in a double-blind review process via the electronic submission system. (Authors and reviewers will remain unknown to each other). The submitting author may contact the abstract coordinator for questions throughout the process. The abstract coordinator may contact submitting authors with questions regarding abstract submissions.
The abstract peer review will be focused on the following criteria, across 6 categories. Reviewers will be asked to respond to abstracts utilizing a 7-point scale, with 1 being strongly disagree and 7 being strongly agree. The 6 categories and their elements are as follows:
Category 1: Objective (Context, Setting, Aim, Goal, Purpose)
- The topic is significant, novel and central to oncology advanced practice.
- The background/significance of the issue or topic is well-summarized and directed to the AP.
- The purpose of the educational project, clinical project/issue, leadership or professional activity or research is clearly defined for oncology advanced practice.
- The role of the oncology advanced practitioner is distinctly described.
Category 2: Methods (Design, Intervention, Approaches, Procedures, Processes)
- How the purpose/objective was addressed is included.
- The implementation methods, interventions, approaches, procedures, and/or processes are described.
Category 3: Results (Findings, Outcome measures, Effects, Discoveries)
- The goals are evaluated according to specific measures.
- The outcomes are applicable to and valuable for oncology advanced practitioners.
Category 4: Conclusions (Interpretation, Summary, Evaluation)
- The outcomes and findings are clearly summarized and discussed.
- The implications for oncology advanced practice are clearly identified.
Category 5: Recommendations (Implications, Proposals, Applications)
- Suggestions, recommendations and/or next steps are included and applicable to advanced practice.
Category 6: Innovation
- The research, clinical/evidence-based practice project, advanced practice initiative/activity is innovative and progressive.
Peer reviewers will also be asked to provide a recommendation for the abstract outcome. Review chairs will make final decisions. All correspondence will be directed to the submitting author, including notification of review outcomes. Only accepted abstracts will be eligible for poster presentation at the conference.
Poster Presentation Requirements
Submitting authors whose abstracts are accepted for poster presentation will be contacted by the abstract coordinator, who will provide additional details and outline next steps in the process, including poster number, specifications for poster development, author tasks, presentation times and any additional requirements for final approval. Poster presentations of accepted abstracts are open to APSHO member submitting authors who are registered and paid conference participants. It is anticipated that the submitting author and presenting author are one and the same. In the event an author other than the submitting author must present, or if there are any questions regarding the role of the presenting author, please contact the abstract organizer. An APSHO member author listed as a co-author on the abstract at the time of submission will be considered to present under extenuating circumstances with approval prior to the conference.
The Presenting Author will complete the following tasks in the submission platform:
- Confirm author profile information
- Upload author photo
- Upload author bio
- Upload final poster in PDF format
- Provide JADPRO Live registration confirmation number
Poster tasks will have specific deadlines. All communication regarding poster presentation will be directly with the submitting/presenting author. If there is a problem anticipated regarding meeting deadlines, the abstract coordinator should be notified.
All posters should be displayed before 7pm EDT on Thursday, November 1, 2018 at the Diplomat Hotel in Hollywood, Florida (conference venue). Please note this date for arranging travel to the conference and contact the abstract coordinator for any questions or concerns.
Poster presentations for accepted abstracts will be held on Friday November 2 and Saturday November 3, 2018 at designated times. The submitting/presenting author should be on site to discuss the poster for the duration of both designated poster sessions during the conference. If extenuating circumstances arise that will prevent the submitting author from presenting, the abstract coordinator must be notified before the first poster session.
Accepted abstracts, posters, and presenting author information will be available in the conference app during the conference as well as on the JADPRO Live official conference website,
www.jadprolive.com. Accepted abstracts will be published in an issue of the
Journal of the Advanced Practitioner in Oncology (JADPRO) following the live conference. Publication of the abstract will not jeopardize future submission of a manuscript; authors are encouraged to continue work to manuscript submission.
Outstanding Poster Award
The second annual Outstanding Poster Award will take place at JADPRO Live 2018 in Hollywood, Florida, and will be granted on-site.
To be eligible for the award, the final pdf of the poster for the accepted abstract must be uploaded to the electronic submission system by 5pm EDT on Thursday, October 18, 2018. All posters submitted by this time will be taken through a review process by the Poster Award Review Committee and considered for the award.
Just as with abstract review, the posters will be evaluated on the following criteria, across 6 categories. The committee will be asked to respond to posters utilizing a 7-point scale, with 1 being strongly disagree and 7 being strongly agree. The 6 categories and their elements are as follows:
Category 1: Objective (Context, Setting, Aim, Goal, Purpose)
- The topic is significant, novel and central to oncology advanced practice.
- The background/significance of the issue or topic is well-summarized and directed to the AP.
- The purpose of the educational project, clinical project/issue, leadership or professional activity or research is clearly defined for oncology advanced practice.
- The role of the oncology advanced practitioner is distinctly described.
Category 2: Methods (Design, Intervention, Approaches, Procedures, Processes)
- How the purpose/objective was addressed is included.
- The implementation methods, interventions, approaches, procedures, and/or processes are described.
Category 3: Results (Findings, Outcome measures, Effects, Discoveries)
- The goals are evaluated according to specific measures.
- The outcomes are applicable to and valuable for oncology advanced practitioners.
Category 4: Conclusions (Interpretation, Summary, Evaluation)
- The outcomes and findings are clearly summarized and discussed.
- The implications for oncology advanced practice are clearly identified.
Category 5: Recommendations (Implications, Proposals, Applications)
- Suggestions, recommendations and/or next steps are included and applicable to advanced practice.
Category 6: Innovation
- The research, clinical/evidence-based practice project, advanced practice initiative/activity is innovative and progressive.
Once evaluated, the committee will indicate overall impressions for each poster and will select the Outstanding Poster Award winner. The poster award winner will receive an Outstanding Poster Award ribbon, Outstanding Poster Award name badge flags for all attending poster authors, special announcement and recognition at JADPRO Live 2018, recognition in the meeting coverage issue of the
Journal of the Advanced Practitioner in Oncology (JADPRO) following the conference, and recognition in the
Advanced Practitioner Society for Hematology and Oncology (APSHO) member newsletter.
Accessing the Submission System
Submitting authors may access the Abstract Submission system below. After reading the guidelines and gathering information for a submission, the submitting author should click on “Create Account” under the New Users area to create an account for the submission system. Once an account is created, the system will provide the user with an access key, allowing the submitting author to access the abstract up until the submission deadline. Submissions that are incomplete at the time of the deadline will no longer be able to be accessed.
For questions or concerns about abstracts and posters for JADPRO Live 2018, please contact Kelley Moore at
kmoore@hbside.com.